Facilitators and barriers for home-based monitoring to time frozen embryo transfers in IVF among women and healthcare providers

• Published in: Human Reproduction Open
• Main Authors: Zaat, T R, de Bruin, J P, Mol, F, van Wely, M
• Other Authors: Netherlands Organisation for Health Research and Development
• Format: Article in Journal/Newspaper
• Language: English
• Published: Oxford University Press (OUP) 2022
• Subjects: Industrial and Manufacturing Engineering; Environmental Engineering; Freya; Antarc*; Antarctica
• Online Access: http://dx.doi.org/10.1093/hropen/hoac021; https://academic.oup.com/hropen/advance-article-pdf/doi/10.1093/hropen/hoac021/43891667/hoac021.pdf; https://academic.oup.com/hropen/article-pdf/2022/3/hoac021/44022884/hoac021.pdf

Abstract STUDY QUESTION What are the facilitators and barriers concerning the implementation of home-based monitoring for natural cycle frozen embryo transfer (NC-FET) from the perspectives of patients and healthcare providers in the Netherlands? SUMMARY ANSWER The most important facilitator was optimal pregnancy chance for both the patients and healthcare providers, and the most important barriers were the risk of missing an ovulation for the patients and laboratory capacity for the healthcare providers. WHAT IS KNOWN ALREADY The share of FET cycles in IVF treatments is increasing and, therefore, it is important to optimize protocols for FET. Monitoring of ovulation, which is used in NC-FET, can be hospital-based (ultrasounds and ovulation triggering) or home-based (LH urine tests). Home-based monitoring has the advantage of being the most natural protocol for FET and provides the feeling of empowerment and discretion for patients. A systematic approach for the implementation of home-based monitoring has to start with an exploration of the perspectives of all stakeholders. STUDY DESIGN, SIZE, DURATION Stakeholders (patients and healthcare providers) involved in the implementation process in the Netherlands participated in the present study. Patients were represented by the Dutch Patient Organisation for Couples with Fertility Problems (FREYA) and healthcare providers were represented by gynaecologists and their society (The Netherlands Society of Obstetrics and Gynaecology), embryologists and their society (The Dutch Federation of Clinical Embryology) as well as fertility doctors. A panel of experts hypothesized on barriers and facilitators for the implementation of home-based monitoring during the proposal phase of the Antarctica-2 randomized controlled trial (RCT). PARTICIPANTS/MATERIALS, SETTING, METHODS All stakeholders were represented during the study. Two different questionnaires were developed in order to investigate facilitators and barriers for the patients and for healthcare providers. The ...